Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Oppenheimer

Ulta Beauty Stock Gets a Much-Needed Boost After Earnings

Beaten-down Ulta Beauty stock is notably higher Friday after the cosmetics retailer's strong earnings report and encouraging outlook.

Kiplinger

Marvell Technology Posts Solid Q3 Beat: Analysts Raise Forecasts, Expect 40%-50% Earnings Growth

Marvell Technology reported upbeat earnings amid exciting earnings season. Analysts raised their price targets, expecting strong growth.

Benzinga

Analyst Expectations For Bank of America's Future

Across the recent three months, 14 analysts have shared their insights on Bank of America (NYSE:BAC), expressing a variety of opinions spanning from bullish to bearish.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Unveiling 13 Analyst Insights On Clearwater Analytics Hldg

Across the recent three months, 13 analysts have shared their insights on Clearwater Analytics Hldg (NYSE:CWAN), expressing a variety of opinions spanning from bullish to bearish.

Benzinga

Demystifying Agilysys: Insights From 8 Analyst Reviews

Analysts' ratings for Agilysys (NASDAQ:AGYS) over the last quarter vary from bullish to bearish, as provided by 8 analysts.

Benzinga

Zscaler Posts Q1 Beat: 8 Analysts Express Concern Around CFO Retirement, Guidance

Zscaler shares tanked despite upbeat Q1 results. The company raised its fiscal-year guidance and announced the departure of its CFO.

Benzinga

Decoding 10 Analyst Evaluations For JPMorgan Chase

Analysts' ratings for JPMorgan Chase (NYSE:JPM) over the last quarter vary from bullish to bearish, as provided by 10 analysts.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Expert Ratings For Citigroup

In the preceding three months, 11 analysts have released ratings for Citigroup (NYSE:C), presenting a wide array of perspectives from bullish to bearish.

Benzinga

Spotlight on AppLovin: Analyzing the Surge in Options Activity

Whales with a lot of money to spend have taken a noticeably bearish stance on AppLovin.

Benzinga

Are Wall Street Analysts Bullish on Lululemon Stock?

Despite Lululemon struggling to keep up with the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock's outlook.

Barchart

1 AI Stock to Buy and Hold for Long-Term Growth

Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors

Barchart

Target Is the Worst S&P 500 Stock After Earnings. Here's Why

Target stock is down big after the retailer missed expectations for its third quarter and slashed its full-year outlook. Here's what Wall Street is saying.

Kiplinger

Tesla and 2 More Stock Picks to Invest in the 'Red Wave' Election Results

These three stocks are well-positioned to benefit from anticipated policy changes amid the upcoming leadership change on Capitol Hill, according to analysts.

Barchart

Shopify Earnings Momentum Accelerates Ahead of Holiday Shopping Season

Shopify stock is surging Tuesday after the e-commerce company beat Q3 expectations and gave a rosy outlook for the holiday shopping season. Here's what you need to know.

Kiplinger

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

Anne Hathaway and Zendaya are latest to join Christopher Nolan’s new film

The actors will join Matt Damon and Tom Holland in the Oppenheimer director’s mysterious next movie

Barchart

5 Buy-Rated Stocks Backed by Strong Fundamentals

Analysts at Oppenheimer believe these 5 fundamentally strong stocks are worth considering now.

Barchart

3 Stocks to Snag for a Comeback in Capital Markets

Explore three standout stocks within capital markets, which are Oppenheimer’s ‘top buy’ ideas right now.

Total Film

Mike Flanagan is producing a new horror movie with Midnight Mass and Oppenheimer stars

The film is a post-apocalyptic zombie movie

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger

Meta Stock Slips as Facebook Parent Ramps Up AI Spending

Meta stock is lower Thursday as concerns over the social media giant's increased spending offset a third-quarter earnings and revenue beat. Here's what you need to know.

Kiplinger

Advanced Micro Devices Stock Sinks as Q4 Guidance Disappoints. What to Know

Advanced Micro Devices is one of the worst S&P 500 stocks Wednesday after the chipmaker's Q4 outlook left Wall Street wanting more.

Barchart

Up 174% in 2024, Is It Too Late to Buy This Breakout Biotech Stock?

After more than doubling in the past year, is this clinical-stage biotech stock still a buy?

The Guardian - UK

Tom Holland set to star in new film from Christopher Nolan

The Spider-Man actor is in talks to star in the project, which is due for release in July 2026, alongside Matt Damon

Barchart

Should You Buy AMD Stock Ahead of Its New AI Chip Launch?

With its new AI chip poised to challenge Nvidia’s data center dominance, is now the time to bet on AMD stock?

Barchart

Microsoft Stock Has Underperformed in 2024, But Can It Catch Up in Q4?

Microsoft stock is underperforming the markets, as well as its Big Tech peers, in 2024. Can MSFT stock play catch-up in the final quarter of the year?

Inverse

Christopher Nolan's Mysterious New Movie Will Repeat 'Oppenheimer's Best Trick

Christopher Nolan's follow-up to 'Oppenheimer' is officially taking shape — and he's set to reunite with a major star.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations